{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:16:35Z","timestamp":1775322995049,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Data on Barrett\u2019s esophagus (BE) and esophageal cancer (EC) outcomes in patients with eosinophilic esophagitis (EoE) are limited. We aimed to determine the risk of prevalent BE (&amp;lt;1\u00a0year after endoscopy), incident BE (\u22651\u00a0year after endoscopy), and incident EC in patients with versus without EoE, and to identify predictors of BE\/EC in EoE patients. We identified adult patients in the Merative MarketScan Database who underwent first-time upper endoscopy between 2008 and 2020. Chi-square analysis compared proportions of patients with versus without EoE who had BE or EC. Multivariate Cox regression determined associations between demographics\/comorbidities and incident BE\/EC in the EoE cohort, adjusting for established BE risk factors. Among 2,947,003 patients who underwent upper endoscopy, 20,588 patients (0.70%) had EoE (mean age 40.6\u00a0years, 63.8% male, gastroesophageal reflux disease in 44.9%). Prevalent BE, incident BE, and incident EC was found in 1.03%, 0.57%, and 0.06% of patients with EoE versus 1.06%, 0.54%, and 0.05% of patients without EoE, respectively (P\u2009=\u20090.13, 0.21, and 0.36, respectively). Among individuals with EoE, older age, male sex, presence of a hiatal hernia, gastroesophageal reflux disease, and location in North Central or Southern USA were independently associated with incident BE. Older age and prevalent BE were independently associated with incident EC. BE\/EC risk in EoE is comparable to that of the baseline population undergoing upper endoscopy. Our findings support current understanding that EoE is not associated with an increased risk of BE\/EC and reinforce that conventional BE screening strategies can be applied in patients with EoE.<\/jats:p>","DOI":"10.1093\/dote\/doae120","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:53:01Z","timestamp":1736333581000},"source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and predictors of Barrett\u2019s esophagus and esophageal cancer in patients with eosinophilic esophagitis"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-1659","authenticated-orcid":false,"given":"Margaret J","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine , Stanford, CA \u00a0","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann W","family":"Hsing","sequence":"additional","affiliation":[{"name":"Department of Medicine and Stanford Cancer Institute, Stanford University School of Medicine , Stanford, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John O","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine , Stanford, CA \u00a0","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"2025012811455630800_ref1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cgh.2013.09.008","article-title":"Prevalence of eosinophilic esophagitis in the United States","volume":"12","author":"Dellon","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025012811455630800_ref2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13441","article-title":"Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies","volume":"43","author":"Arias","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025012811455630800_ref3","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"2025012811455630800_ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox050","article-title":"The relationship between eosinophilic esophagitis and esophageal cancer","volume":"30","author":"Syed","year":"2017","journal-title":"Dis Esophagus"},{"key":"2025012811455630800_ref5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41395-018-0052-5","article-title":"The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort","volume":"113","author":"Warners","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2025012811455630800_ref6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.gie.2014.02.012","article-title":"The natural history of steroid-na\u00efve eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years","volume":"80","author":"Lipka","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"2025012811455630800_ref7","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1053\/j.gastro.2003.09.024","article-title":"Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years","volume":"125","author":"Straumann","year":"2003","journal-title":"Gastroenterology"},{"key":"2025012811455630800_ref8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/0016-5085(78)90710-2","article-title":"Eosinophilic esophagitis in a patient with vigorous achalasia","volume":"74","author":"Landres","year":"1978","journal-title":"Gastroenterology"},{"key":"2025012811455630800_ref9","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0016-5085(77)80034-6","article-title":"Eosinophilic gastroenteritis with esophageal involvement","volume":"72","author":"Dobbins","year":"1977","journal-title":"Gastroenterology"},{"key":"2025012811455630800_ref10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ajg.2011.7","article-title":"Prevalence of esophageal eosinophils in patients with Barrett's esophagus","volume":"106","author":"Ravi","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2025012811455630800_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.02.005","article-title":"Characterization of prevalent, post-endoscopy, and incident esophageal cancer in the United States: a large retrospective cohort study","volume":"20","author":"Vajravelu","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025012811455630800_ref12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/dote.12141","article-title":"Administrative coding is specific, but not sensitive, for identifying eosinophilic esophagitis","volume":"27","author":"Rybnicek","year":"2014","journal-title":"Dis Esophagus"},{"key":"2025012811455630800_ref13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MCG.0000000000001491","article-title":"Disease burden and treatment patterns associated with eosinophilic esophagitis in the United States: a retrospective claims study","volume":"56","author":"Lu","year":"2022","journal-title":"J Clin Gastroenterol"},{"key":"2025012811455630800_ref14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-019-1992-x","article-title":"Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study","volume":"21","author":"Simon","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025012811455630800_ref15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"2025012811455630800_ref16","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2025012811455630800_ref17","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2015.07.009","article-title":"Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study","volume":"149","author":"Nguyen","year":"2015","journal-title":"Gastroenterology"},{"key":"2025012811455630800_ref18","doi-asserted-by":"crossref","first-page":"e006640","DOI":"10.1136\/bmjopen-2014-006640","article-title":"NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study","volume":"5","author":"Masclee","year":"2015","journal-title":"BMJ Open"},{"key":"2025012811455630800_ref19","volume-title":"Merative AA, Michigan, USA","author":"Micromedex\u00ae (electronic version)"},{"key":"2025012811455630800_ref20","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201110002-00020","article-title":"Barrett's esophagus in eosinophilic esophagitis, a coincidence or correlation?-A retrospective case-control study of 365 patients: 20","volume":"106","author":"Kumar","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2025012811455630800_ref21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MCG.0b013e3182568792","article-title":"Inverse association of esophageal eosinophilia and Barrett esophagus","volume":"46","author":"Saboorian","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"2025012811455630800_ref22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","article-title":"Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner","volume":"145","author":"Schoepfer","year":"2013","journal-title":"Gastroenterology"},{"key":"2025012811455630800_ref23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10388-018-0648-2","article-title":"Barrett's esophagus is negatively associated with eosinophilic esophagitis in Japanese subjects","volume":"16","author":"Takashima","year":"2019","journal-title":"Esophagus"},{"key":"2025012811455630800_ref24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1159\/000531060","article-title":"Barrett's esophagus in eosinophilic esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS)","volume":"41","author":"Scherer","year":"2023","journal-title":"Dig Dis"},{"key":"2025012811455630800_ref25","doi-asserted-by":"crossref","first-page":"G31","DOI":"10.1152\/ajpgi.00321.2021","article-title":"Molecules involved in the development of Barrett's esophagus phenotype in chronic eosinophilic esophagitis","volume":"323","author":"Upparahalli Venkateshaiah","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2025012811455630800_ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11882-015-0592-3","article-title":"The immunologic mechanisms of eosinophilic esophagitis","volume":"16","author":"Hill","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"2025012811455630800_ref27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jcmgh.2022.01.023","article-title":"The immune underpinnings of Barrett's-associated adenocarcinogenesis: a retrial of nefarious immunologic co-conspirators","volume":"13","author":"Tambunting","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025012811455630800_ref28","first-page":"126","article-title":"Mortality in eosinophilic esophagitis - a nationwide, population-based matched cohort study from 2005 to 2017","volume":"2021","author":"R\u00f6jler","journal-title":"Ups J Med Sci"},{"key":"2025012811455630800_ref29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(18)31388-6","article-title":"Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial","volume":"392","author":"Jankowski","year":"2018","journal-title":"Lancet"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/1\/doae120\/61372973\/doae120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/1\/doae120\/61372973\/doae120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:46:15Z","timestamp":1738064775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doae120\/7945356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doae120","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,7]]},"article-number":"doae120"}}